Showing results (11-20 of 510) with videos related to
Sort By:
Pageof 51
European Urology|June 8, 2006
Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumorUgo De Giorgi, Giovanni Rosti, Michele Aieta, et al.Molecular Cancer Therapeutics|March 16, 2005
Imatinib and gastrointestinal stromal tumors: Where do we go from here?Ugo De Giorgi, Jaap VerweijFrontiers in Immunology|March 2, 2023
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell TumorsGiuseppe Schepisi, Caterina Gianni, Maria Concetta Cursano, et al.Future Oncology (London, England)|June 23, 2026
Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practiceStephen J Freedland, Ugo De GiorgiSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2017
Role of narrative-based medicine in proper patient assessmentGiovanni RostiAdvances in Urology|May 5, 2018
Immune-Related Concepts in Biology and Treatment of Germ-Cell TumorsMichal Chovanec, Ugo De Giorgi, Michal MegoFrontiers in Endocrinology|June 28, 2021
Corrigendum: Editorial: Testicular Cancer: New Insights on the Origin, Genetics, Treatment, Fertility, General Health, Quality of Life and Sexual FunctionAndrea Garolla, Ugo De Giorgi, Domenico MilardiFuture Oncology (London, England)|March 19, 2019
Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical managementChiara Casadei, Giuseppe Schepisi, Cecilia Menna, et al.International Journal of Molecular Sciences|June 2, 2021
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic ReviewGiuseppe Schepisi, Caterina Gianni, Sara Bleve, et al.Frontiers in Endocrinology|March 13, 2019
Psychosocial Issues in Long-Term Survivors of Testicular CancerGiuseppe Schepisi, Silvia De Padova, Delia De Lisi, et al.Pageof 51